| 1 | | $858B | $902.71 | -1.29% | |
| 2 | | $396B | $164.38 | -0.37% | |
| 3 | | $342B | $193.40 | +0.28% | |
| 4 | | $299B | $117.84 | -1.04% | |
| 5 | | $198B | $113.86 | +0.67% | |
| 6 | | $172B | $320.56 | -1.17% | |
| 7 | | $168B | $471.82 | -1.89% | |
| 8 | | $162B | $28.56 | +0.03% | |
| 9 | | $137B | $358.92 | +0.28% | |
| 10 | Regeneron Pharmaceuticals | $125B | $1,131.50 | -1.66% | |
| 11 | | $121B | $468 | -0.12% | |
| 12 | | $120B | $81.60 | +0.28% | |
| 13 | | $115B | $89.89 | +0.56% | |
| 14 | | $100B | $387.98 | -2.46% | |
| 15 | | $98.7B | $48.70 | -2.41% | |
| 16 | | $98.1B | $78.72 | -0.32% | |
| 17 | | $85.7B | $189.23 | +1.41% | |
| 18 | | $70.6B | $128.60 | -2.13% | |
| 19 | | $67.2B | $232.67 | -0.25% | |
| 20 | | $65.4B | $504.17 | -2.06% | |
| 21 | | $46.1B | $234.97 | -0.54% | |
| 22 | | $40.2B | $66.81 | +1.2% | |
| 23 | | $38.9B | $472.35 | +0.85% | |
| 24 | | $38.9B | $85.09 | -2.7% | |
| 25 | | $36B | $244.87 | +0.04% | |
